We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Salt Lake Potash Limited | LSE:SO4 | London | Ordinary Share | AU000000SO44 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.45 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSO4
RNS Number : 1030E
Salt Lake Potash Limited
04 May 2017
Hot Features
Premium
4 May 2017 AIM/ASX Code: SO4
SALT LAKE POTASH LIMITED
Appendix 3B
-------------------------
The Directors of Salt Lake Potash Limited advise that the following Appendix 3B announcement has been released on the Australian Securities Exchange ("ASX"), as required under the listing rules of the ASX.
For further information, please visit www.saltlakepotash.com.au or contact:
Matthew Syme/ Salt Lake Potash Limited Tel: +61 8 9322 6322 Sam Cordin Colin Aaronson/Richard Grant Thornton UK LLP Tel: +44 (0)207 383 5100 Tonthat/Daniel Bush
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity SALT LAKE POTASH LIMITED ------------------------- ABN 98 117 085 748 ---------------
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities Ordinary Shares
issued or to be issued
Number of +securities
issued or to be issued
(if known) or maximum
number which may be
2 issued 30,700,000
3 Principal terms of Fully paid ordinary shares
the +securities (e.g.
if options, exercise
price and expiry date;
if partly paid +securities,
the amount outstanding
and due dates for
payment; if +convertible
securities, the conversion
price and dates for
conversion)
--------------------------------
4 Do the +securities Yes
rank equally in all
respects from the
+issue date with an
existing +class of
quoted +securities?
If the additional
+securities do not
rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
---------------------------------------
5 Issue price or consideration $0.43
---------------------------------------
6 Purpose of the issue To provide funding for the Company's
(If issued as consideration planned exploration and development
for the acquisition activities for the Sulphate
of assets, clearly of Potash Projects and for general
identify those assets) working capital.
-----------------------------------------------------------------
6a Is the entity an +eligible Yes
entity that has obtained
security holder approval
under rule 7.1A?
If Yes, complete sections
6b - 6h in relation
to the +securities
the subject of this
Appendix 3B, and comply
with section 6i
-----------------------------------------------------------------
6b The date the security 30 November 2016
holder resolution
under rule 7.1A was
passed
-----------------------------------------------------------------
Number of +securities
issued without security
holder approval under
6c rule 7.1 17,317,241
-----------------------------------------------------------------
Number of +securities
issued with security
holder approval under
6d rule 7.1A 13,382,759
-----------------------------------------------------------------
6e Number of +securities Nil
issued with security
holder approval under
rule 7.3, or another
specific security
holder approval (specify
date of meeting)
-----------------------------------------------------------------
6f Number of +securities Nil
issued under an exception
in rule 7.2
-----------------------------------------------------------------
6g If +securities issued Yes
under rule 7.1A, was
issue price at least Issue date: 4 May 2017
75% of 15 day VWAP Issue price: $0.43
as calculated under 15 day VWAP: $0.48 (Source:
rule 7.1A.3? Include IRESS)
the +issue date and
both values. Include
the source of the
VWAP calculation.
-----------------------------------------------------------------
6h If +securities were Not Applicable
issued under rule
7.1A for non-cash
consideration, state
date on which valuation
of consideration was
released to ASX Market
Announcements
-----------------------------------------------------------------
6i Calculate the entity's 7.1 - 2,576,898
remaining issue capacity
under rule 7.1 and
rule 7.1A - complete
Annexure 1 and release
to ASX Market Announcements
7.1A - Nil
-----------------------------------------------------------------
7 +Issue dates 4 May 2017
Note: The issue date
may be prescribed
by ASX (refer to the
definition of issue
date in rule 19.12).
For example, the issue
date for a pro rata
entitlement issue
must comply with the
applicable timetable
in Appendix 7A.
Cross reference: item
33 of Appendix 3B.
Number +Class
------------------------------------- --------------------------
Number and +class
of all +securities
quoted on ASX (including
the +securities in
8 section 2 if applicable) 164,707,596 Ordinary Shares
------------------------------------- --------------------------
Number +Class
------------------------------------- --------------------------
Class A Performance
Shares
Class B Performance
Shares
Class C Performance
Shares
Incentive Options
exercise price
$0.40, expiry
5,000,000 date 29 April
2019
7,500,000 Incentive Options
exercise price
$0.50, expiry
10,000,000 date 29 April
2020
750,000 Incentive Options
exercise price
$0.50, expiry
date 29 April
2021
750,000
Performance rights
which are subject
to various performance
conditions to
1,000,000 be satisfied
Number and +class prior to the
of all +securities relevant expiry
not quoted on ASX dates between
(including the +securities 30 June 2018
9 in section 2 if applicable) 3,000,000 and 30 June 2021
------------------------------------- --------------------------
10 Dividend policy (in Not Applicable
the case of a trust,
distribution policy)
on the increased capital
(interests)
-----------------------------------------------------------------
Part 2 -- Pro rata issue
11 Is security holder Not Applicable
approval required?
---------------
12 Is the issue renounceable Not Applicable
or non-renounceable?
---------------
13 Ratio in which the Not Applicable
+securities will be
offered
14 +Class of +securities Not Applicable
to which the offer
relates
---------------
15 +Record date to determine Not Applicable
entitlements
---------------
16 Will holdings on different Not Applicable
registers (or subregisters)
be aggregated for calculating
entitlements?
---------------
17 Policy for deciding Not Applicable
entitlements in relation
to fractions
---------------
18 Names of countries Not Applicable
in which the entity
has security holders
who will not be sent
new offer documents
Note: Security holders
must be told how their
entitlements are to
be dealt with.
Cross reference: rule
7.7.
---------------
19 Closing date for receipt Not Applicable
of acceptances or renunciations
---------------
20 Names of any underwriters Not Applicable
---------------
21 Amount of any underwriting Not Applicable
fee or commission
---------------
22 Names of any brokers Not Applicable
to the issue
---------------
23 Fee or commission payable Not Applicable
to the broker to the
issue
---------------
24 Amount of any handling Not Applicable
fee payable to brokers
who lodge acceptances
or renunciations on
behalf of security
holders
---------------
25 If the issue is contingent Not Applicable
on security holders'
approval, the date
of the meeting
---------------
26 Date entitlement and Not Applicable
acceptance form and
offer documents will
be sent to persons
entitled
---------------
27 If the entity has issued Not Applicable
options, and the terms
entitle option holders
to participate on exercise,
the date on which notices
will be sent to option
holders
---------------
28 Date rights trading Not Applicable
will begin (if applicable)
---------------
29 Date rights trading Not Applicable
will end (if applicable)
---------------
30 How do security holders Not Applicable
sell their entitlements
in full through a broker?
---------------
31 How do security holders Not Applicable
sell part of their
entitlements through
a broker and accept
for the balance?
---------------
32 How do security holders Not Applicable
dispose of their entitlements
(except by sale through
a broker)?
---------------
33 +Issue date Not Applicable
---------------
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) +Securities described in Part 1
(b) All other +securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing
the information or documents
35 If the +securities are +equity securities, the
names of the 20 largest holders of the additional
+securities, and the number and percentage of
additional +securities held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting
out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of +securities Not Applicable
for which +quotation
is sought
39 +Class of +securities Not Applicable
for which quotation
is sought
-----------------
40 Do the +securities Not Applicable
rank equally in all
respects from the +issue
date with an existing
+class of quoted +securities?
If the additional +securities
do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
41 Reason for request Not Applicable
for quotation now
Example: In the case
of restricted securities,
end of restriction
period
(if issued upon conversion
of another +security,
clearly identify that
other +security)
-----------------
Number +Class
--------------- ---------
42 Number and +class of
all +securities quoted
on ASX (including the
+securities in clause
38)
--------------- ---------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: ............................................................ Date: 4 May 2017
(Director/Company secretary)
Print name: Sam Cordin
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
-------------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from which the
placement capacity is calculated
-------------------------------------------------------------------------------------------
Insert number of fully paid
+ordinary securities on issue
12 months before the +issue
date or date of agreement
to issue 132,227,596
-------------------------------------------------------------- ---------------------------
Add the following:
* Number of fully paid +ordinary securities issued in 1,600,000 (7 June 2016)
that 12 month period under an exception in rule 7.2 17,317,241 (4 May 2017)
* Number of fully paid +ordinary securities issued in
that 12 month period with shareholder approval
* Number of partly paid +ordinary securities that
became fully paid in that 12 month period
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- ---------------------------
Subtract the number of fully Nil
paid +ordinary securities
cancelled during that 12
month period
-------------------------------------------------------------- ---------------------------
"A" 133,827,596
-------------------------------------------------------------- ---------------------------
Step 2: Calculate 15% of "A"
----------------------------------------------------------------------------------------------
"B" 0.15
[Note: this value cannot be
changed]
------------------------------------------------------------- -------------------------------
Multiply "A" by 0.15 20,074,139
------------------------------------------------------------- -------------------------------
Step 3: Calculate "C", the amount of placement capacity
under rule 7.1 that has already been used
----------------------------------------------------------------------------------------------
Insert number of +equity
securities issued or agreed
to be issued in that 12 month 180,000 (9 September 2016)
period not counting those 17,317,241 (4 May 2017)
issued:
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------------- -------------------------------
"C" 17,497,241
------------------------------------------------------------- -------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
----------------------------------------------------------------------------------------------
"A" x 0.15
Note: number must be same
as shown in Step 2 20,074,139
------------------------------------------------------------- -------------------------------
Subtract "C"
Note: number must be same
as shown in Step 3 17,497,241
------------------------------------------------------------- -------------------------------
Total ["A" x 0.15] - "C" 2,576,898
[Note: this is the remaining
placement capacity under rule
7.1]
------------------------------------------------------------- -------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible
entities
--------------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from which the
placement capacity is calculated
--------------------------------------------------------------------------------------------
"A"
Note: number must be same
as shown in Step 1 of Part
1 133,827,596
-------------------------------------------------------------- ----------------------------
Step 2: Calculate 10% of "A"
--------------------------------------------------------------------------------------------
"D" 0.10
Note: this value cannot be
changed
-------------------------------------------------------------- ----------------------------
Multiply "A" by 0.10 13,382,759
-------------------------------------------------------------- ----------------------------
Step 3: Calculate "E", the amount of placement capacity
under rule 7.1A that has already been used
--------------------------------------------------------------------------------------------
Insert number of +equity 13,382,759 (4 May 2017)
securities issued or agreed
to be issued in that 12 month
period under rule 7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- ----------------------------
"E" 13,382,759
-------------------------------------------------------------- ----------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
----------------------------------------------------------------
"A" x 0.10
Note: number must be same
as shown in Step 2 13,382,759
------------------------------ --------------------------------
Subtract "E"
Note: number must be same
as shown in Step 3 13,382,759
------------------------------ --------------------------------
Total ["A" x 0.10] - "E" Nil
Note: this is the remaining
placement capacity under rule
7.1A
------------------------------ --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUOUVRBVAVRAR
(END) Dow Jones Newswires
May 04, 2017 02:00 ET (06:00 GMT)
1 Year Salt Lake Potash Chart |
1 Month Salt Lake Potash Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
